11.2. Myasthenia Gravis (Acquired and Congenital)
- General Features:
- Incidences 4/1,000,000; prevalence 0.5–5/100,000
- Peak incidence 25–30 years of age
- Females greater than males; older age males > females
- Clinical Presentation:
- Onset is subacute
- Ptosis of one eyelid most common early sign
- Symptoms and signs vary over time
- Proximal muscle weakness particularly of the lower extremities greater than distal weakness is a common pattern
- Weakness may increase during the day
- Fatigue with exercise of the specific muscle group that is exercised (chewing, swallowing, and holding the head up)
- Clinical involvement is purely ocular in 15% of patients
- Aggravating features for weakness:
- Exercise
- Heat
- Menses
- Infection (viral)
- Pregnancy
- Stress
- Hypokalemia
- Thyroid dysfunction
- 40–50% of patients present with ptosis or diplopia; mild ocular deviation often causes blurred vision (non-foveation)
- 20–30% of patients have ocular complaints and muscle weakness
- Bulbar complaints at initial presentation occur in approximately 20% of patients
- Clinical examination:
- Ptosis (usually asymmetrical); lifting the ptotic lid causes droop of the other lid
- Normal pupils
- III, IV or Vth nerve weakness
- Pseudo Intranuclear ophthalmoplegia
- Cogan's twitch sign (over activation of co-innervated yoked muscles; over stimulation of levator palpebrae after fatigue of inferior oblique and superior rectus)
- Lower facial muscle weakness (transverse smile); prominent jaw weakness; patients may hold jaw closed with their hand
- Neck flexor and extensor muscle weakness to similar degree (flexors weak with myopathy and extensors weak with motor neuron disease)
- Triple furrowed tongue (differential weakness of intrinsic tongue muscles with unequal tongue muscle contraction)
- Peek-a-boo sign (slight opening of the eyelids occurs after forced eyelid closure (weakness of the orbicularis oculi)
- Sluggish gag reflex, difficulty swallowing liquids and nasal speech
- Weakness proximal greater than distal; lower extremities are involved to greater degree than upper
- Weakness worsened by repetitive use
- Reflexes normal to increased (spread of acetylcholine sensitivity of the sarcolemmal membrane)
- Respiratory weakness may appear as an isolated sign
- Isolated distal limb weakness and neck extensor weakness
- Difficulty weaning a patient from a respirator
- Rarely isolated bulbar weakness
Course of the Illness
- 90–95% of patients develop extraocular muscle weakness
- 20% may have only ocular involvement
- 40% develop bulbar weakness
- 60–75% extremity weakness
- Patients who present with pure extraocular motor manifestation that generalize do so within two years
- Mortality now at less than 3%
- After three years, approximately 60% of patient with ocular myasthenia gravis generalize
Associated Medical Illnesses
- Thyroid disorder (10%; most commonly hyperthyroidism)
- Rheumatoid arthritis
- Platelet abnormalities (ITP) idiopathic thrombocytopenic purpura
- Antibodies to gastric parietal cells with B12 deficiency
- Diabetes mellitus
- Hemolytic anemia
- Sjögren's syndrome
- Lymphoma
- Nonspecific immunologic abnormalities:
- Serum anti-muscle Ab
- Antibodies against thyroid, gastric parietal cell and nuclear antigens
Thymic Abnormalities
- Thymic pathology in 75–80% of patients
- Ten to 15% have thymoma; most frequently seen in 55–65 year old males
- Young women demonstrate thymic hyperplasia
EMG Evaluation
- Jolly response is positive in 85% of patient with generalized MG
- At least a 10% decrement between the first and fourth compound muscle action potential (CMAP) at 2–3 HZ
- 30–40% will have negative repetitive stimulation in pure ocular MG
- In the face of a decremental response:
- Maximal contraction of the muscle for 30 to 60 seconds abolishes the decrement (post-tetanic potentiation) for 120 seconds after exercise
- The decrement is increased (post-tetanic exhaustion) for 120–240 seconds following exercise
- Single fiber electromyography:
- Jitter (latency variability between single muscle fiber potentials) innervated by the same axon is increased in MG
- Blocking (absence of the second muscle fiber potential) may be noted
- Single fiber EMG is abnormal in 95–100% of MG patients
- Laboratory evaluation:
- Antibodies to acetylcholine receptor:
- Positive in 85–90% of patients with generalized MG
- Positive in 30–40% of patients with ocular MG
- Pulmonary function tests
- Abnormal spirometry
- Decreased mean ventilatory volume
- Fatigue
- Restrictive pattern
- CT scan of the chest
- Evaluation for thymic tumors
- Blood evaluation to rule out associated autoimmune disease
Serum Antibodies to Muscle Specific Receptor Tyrosine Kinase (MuSK)
- Clinical Features:
- Found in generalized seronegative MG patients; 20% of MG patients
- All patients were women
- Onset between 12–59 years of age
- Neck, shoulder or respiratory weakness
- Less prominent ocular muscle involvement
- Variable response to cholinesterase inhibitors
- EMG may be myopathic
Myasthenia Gravis with Thymoma
- Predominantly a disease of middle aged males
- Clinical Presentation:
- Ptosis is frequent; less often other cranial nerves are involved
- May lose reflexes
- May have sensory complaints: paraesthesia; deep muscle ache
- Difficulty initiating movements
- Anti-striated A-band muscle antibodies
- Patients with serum antibodies to the alpha 1 or alpha 3 containing neuronal AChR subunits had autonomic symptoms
- Paraneoplastic disease associated with thymoma (lymphoepithelial thymoma in one patient) developed in sequential order:
- Limbic encephalitis
- Neuromyotonia (with hyperhidrosis and motor neuropathy)
- Myasthenia gravis
- Associated diseases with thymoma:
- Hypogammaglobinemia (Good's syndrome)
- Macrocytic anemia, thrombocytosis and hypogammaglobinemia
- Thymoma-associated autoimmune enteropathy
- Loss of CD19 + lymphocytes in peripheral blood
- Pure red cell aplasia
- Polymyositis (rare)
- Intersitial myocarditis
Differential Diagnosis of Myasthenia Gravis (Ocular Involvement Alone)
- Brainstem lesions affecting the IIIrd nerve (pupil often involved); pseudo internuclear ophthalmoplegia from MG (convergence often affected)
- Horner's Syndrome (pupil is miotic)
- Painless ptosis over several days (MG)
- Alternating and recurrent ptosis (MG)
- Graves ophthalmopathy:
- All ocular muscles enlarge
- Pathological retraction of the globe
- Forced ductions demonstrate decreased motility
- Kearns-Sayre Syndrome
- Progressive external ophthalmoplegia
- Symmetric ptosis
- Associated myocardiopathy nerve and proximal muscle weakness
- Slow saccades; MG rapid saccades within limits of weakness
- Aneurysm (P-COM)
- Retroorbital pain
- Pupillary involvement; often oval
- Diabetes III nerve involvement:
- Sudden onset of dysfunction
- No pupillary involvement
- Autoimmune thyroid disease
- May coexist with MG
- Periorbital pain
Differential Diagnosis of Generalized MG Central Disorders
- Brainstem lesions (associated long tract signs)
- Basilar meningitis (fever, stiff neck)
- Demyelinating disease (sensory loss: cerebellar signs; optic nerve dysfunction)
Neuromuscular disease
- ALS (bulbar presentation)
- Diphtheria (pupils involved)
- Polymyositis (swallowing)
- Inclusion body myositis (swallowing)
- Granulomatous myopathy
Neuromuscular Junction Disease
- Lambert–Eaton Syndrome:
- Autonomic involvement (dry mouth)
- "Load in the pants" gait
- Minimal ptosis (less cranial nerve involvement)
- Exercise induced increased strength
- Congenital myasthenic syndromes
- Initiation at birth
- Gradual deterioration of motor function
Congenital Myasthenia Syndrome Resembling Lambert–Eaton (LES) Pre-Synaptic Syndrome
- EMG characteristics of LES
- Defect of the presynaptic voltage gated calcium channels (VGCC) in the synaptic release complex
- EMG:
- CMAP is low at rest
- 100% facilitation at high stimulation frequencies
Paucity of Synaptic Vesicles and Reduced Quantal Release
- Symptoms resemble those of acquired MG
- Defect of synthesis or axonal transport of vesicle precursors to axon terminals
- Less than 20% of the usual Ach quanta released by a nerve impulse
- Partial response to acetylcholinesterase inhibitors
Post Synaptic Congenital Myasthenia Syndrome (CMS)
- General features:
- All are caused by mutations in AchR subunit genes
- Increase or decrease the synaptic response to Ach
- The genes coding for alpha and delta subunits of the AchR are on chromosome 2q; beta and epsilon subunits as on different loci on chromosome 17p
End Plate Choline Acetyl Transferase Deficiency
- General Features:
- No AchR defect
- MEPP amplitudes normal at rest
- Decreases during 10-Hz stimulation for 10 minutes
- Defect in resynthesis or packaging of vesicular Ach quanta
- Clinical Presentation:
- Sudden episodes of apnea
- Precipitants are fever excitement or infection
- Presents at birth with bulbar dysfunction respiratory weakness (ventilatory support) and hypotonia
- Recurrent apneic attacks with bulbar paralysis; may occur in later life
- Some patients are not breathing at birth and experience attacks during infancy or early childhood
- Ptosis and fatigable weakness may persist between attacks
- Extraocular muscles may be spared
- Sluggish pupillary light reflex
- Refractory to cholinesterase inhibitors
- EMG:
- Pathology:
- Absence of AchR at the synaptic cleft
- Small nerve terminals encased by Schwann cells; decreased quantal release
Increased Response to Acetylcholine
- Slow-Channel Syndromes:
- Varied clinical presentation:
- Early severe syndrome
- Late presentation with little disability
- Cervical wrist and finger extensor muscle involvement
- Prolonged openings of the AchR
- AD inheritance
- Quinine may be effective
- EMG:
- Repetitive CMAP and end plate potentials demonstrate staircase summation with depolarization block
Decreased Response to Acetylcholine
- General features:
- Clinical symptoms resemble acquired MG
- Mild to severe weakness
- Due to low affinity of ligand
- Due to gating abnormality
- Due to mode switching kinetics
Decreased Response to Acetylcholine
Fast Channel Syndromes
- General Features (3 syndromes):
- All syndromes have brief channel openings
- Decreased probability of channel opening
- Responsive to:
- Pyridostigmine
- 3.4 diamino pyridine
- Low-Affinity fast channel syndromes:
- Normal AchR and end plate morphology
- Infrequent and briefer than normal channel openings
- Mutation of the extracellular domain of the epsilon subunit (ε P121L)
- Fast channel syndrome due to a gating abnormality
- Mutation of the M3 domain of the alpha subunit (α V285I)
- Small MEPP and decreased miniature end plate conductance
- Slow channel-opening rate constant beta
- Fast channel-closing rate constant alpha
- Reduced probability of channel opening
- Fast channel syndrome due to mode switching kinetics
- In frame duplication in the long cytoplasmic loop of E, E1254 in 18
- Gate opens more slowly
- Closes more rapidly than normal
Primary Acetylcholine Receptor Deficiency with or without Minor Kinetic Abnormalities
- Homozygous and heterozygous recessive mutation in AchR subunit genes
- Mild to severe symptoms similar to acquired autoimmune MG
- Partial response to acetylcholinesterase inhibition and 3,4-diaminopyridine
- Severe end plate AchR deficiency:
- Mutations of the ε subunit of the AchR
Congenital Myasthenic Syndromes Associated with Pectin Deficiency
- Pectin is an intermediate filament linking protein; concentrated at sites of mechanical stress
- In association with recessive form of epidermolysis bullosa simplex and muscular dystrophy
- Pectin is decreased in skin and absent from muscle in these conditions
Differential Diagnosis of Congenital Myasthenic Syndrome in Adults
- Mitochondrial myopathy
- Motor neuron disease
- FSH dystrophy
- LGMD
- Sero positive and sero negative autoimmune MG
|